Clinical Trial Update: A Research Study of VCT220 in Adult Chinese Participants With Obesity [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating VCT220 for obesity in adult Chinese participants is currently active but not recruiting, sponsored by Vincentage Pharma Co.,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• VCT220

Snippet

Sponsor: Vincentage Pharma Co., Ltd | Conditions: Obesity, Overweight | Phase 3 | Status: ACTIVE_NOT_RECRUITING